US Activist Hedge Fund Institutional SEC 13D 13G — June 23, 2026

23-06-2026

The Philip & Daniele Barach Family Trust and its trustees filed an amended Schedule 13D disclosing beneficial ownership of 5,414,686 shares of Celularity Inc. Class A Common Stock, representing 15.8% of outstanding shares. This ownership arises from a $10 million financing in December 2025, including a convertible note and warrants. However, the trust's right to acquire additional convertible notes and warrants expired on June 19, 2026, reducing potential ownership by 2,043,979 shares.

• · The Trust's right to purchase additional convertible notes of up to $2M expired on June 19, 2026.
• · Warrants to purchase 3,707,457 shares became exercisable on June 19, 2026 at $2.00 per share.
• · Conversion price of the convertible note is $1.66 per share.
• · No transactions in Class A Common Stock by Reporting Persons in past 60 days except as described.
• · Each Reporting Person disclaims sole voting or dispositive power; all power is shared.

23-06-2026

Abel Avellan, Chairman and CEO of AST SpaceMobile, filed Amendment No. 18 to Schedule 13D, reporting beneficial ownership of 78,252,625 shares of Class A Common Stock (20.8% of class) and a 71.6% voting interest via Class C Common Stock. On June 22, 2026, AA Gables 2, LLC (controlled by Avellan) entered into a variable prepaid forward transaction with Citibank covering up to 2,500,000 shares, receiving approximately $146.7 million upfront for personal financial planning and liquidity purposes. Avellan retains voting rights on the pledged securities.

• · The forward transaction has a Floor Price of $59.58 and a Cap Price of $111.72 per share.
• · Settlement dates for the four components are in March 2028.
• · AA Gables 2 pledged 2,500,000 AST Common Units to secure its obligations.
• · Avellan disclaims beneficial ownership of shares held by other Stockholder Parties.

23-06-2026

Docler Holding S.a r.l. and its affiliates, including Byborg Enterprises S.A., The Million S.a. r.l., and Gyorgy Gattyan, filed an amended Schedule 13D disclosing aggregate beneficial ownership of 15,064,516 shares of Playboy, Inc. common stock, representing 13.0% of outstanding shares as of June 22, 2026. The filing also details a Backstop Agreement entered into on June 18, 2026, under which The Million S.a. r.l. and other purchasers agreed to backstop the company's stock repurchase, with a fee of 5.0% of the unused commitment payable in shares or cash. However, the filing notes that the company repurchased and canceled 1,904,762 shares on June 18, 2026, reducing total outstanding shares from 117.5 million to approximately 115.6 million, which increased the reporting group's ownership percentage.

• · The Backstop Agreement obligates The Million and other purchasers to buy shares if Playboy fails to make scheduled repurchases under the Stock Repurchase Agreement.
• · The backstop fee is 5.0% of the unused commitment, payable in shares or cash if the issuance would cause ownership to exceed 29.99%.
• · The filing was made on June 23, 2026, with an event date of June 18, 2026.
• · Playboy, Inc. was formerly known as PLBY Group, Inc. (name change on February 11, 2021) and Mountain Crest Acquisition Corp. (name change on February 19, 2020).

23-06-2026

On June 23, 2026, The Cigna Group and its wholly owned subsidiary Cigna Ventures, LLC filed a Schedule 13G disclosing beneficial ownership of 3,444,630 shares of Omada Health, Inc. common stock, representing a 5.8% stake. The filing indicates passive investment intent under Rule 13d-1(d), with shared voting and dispositive power held by The Cigna Group.

• · The filing is made pursuant to Rule 13d-1(d), indicating passive investment intent.
• · Cigna Ventures, LLC is a wholly owned subsidiary of The Cigna Group.
• · The Cigna Group may be deemed to have shared voting and dispositive power over the shares held by Cigna Ventures.
• · The address of the principal business office for the Reporting Persons is 900 Cottage Grove Rd., Bloomfield, CT 06002.
• · The filing includes a Joint Filing Agreement between The Cigna Group and Cigna Ventures, LLC.

23-06-2026

L1 Capital Global Opportunities Master Fund, Ltd. filed a Schedule 13G on June 23, 2026, disclosing beneficial ownership of 851,700 shares of Tianci International, Inc. (CIIT) common stock, representing 9.99% of the 7,673,907 shares outstanding. The holding includes 750,000 shares of common stock and 101,700 pre-funded warrants, all subject to a 9.99% beneficial ownership limitation. The filing is a passive investment under Rule 13d-1(c), indicating the fund does not intend to influence control of the issuer.

• · The filing is made under Rule 13d-1(c), confirming a passive investment intent.
• · The beneficial ownership limitation of 9.99% prevents inclusion of an additional 298,300 pre-funded warrants and 2,300,000 warrants.
• · The percentage calculation is based on 7,673,907 shares outstanding per the issuer's June 2026 filings.
• · David Feldman and Joel Arber, as directors of L1 Capital, may be deemed beneficial owners but disclaim such ownership for other purposes.

23-06-2026

S2G Investments, LLC filed a Schedule 13G with the SEC on June 23, 2026, disclosing beneficial ownership of 2,575,401 shares of Faeth Therapeutics, Inc. (formerly Sensei Biotherapeutics, Inc.) common stock, representing 9.99% of the outstanding shares as of June 15, 2026. The shares were acquired upon conversion of Series B Non-Voting Convertible Preferred Stock, and S2G has elected a beneficial ownership limitation of 9.99%, meaning it does not beneficially own the additional 344,271 common shares underlying its remaining Series B Preferred shares. The filing indicates passive investment intent, with no purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · S2G Investments, LLC serves as the investment manager to S2G Builders Food & Agriculture Fund III, LP, which holds the securities directly.
• · The beneficial ownership limitation of 9.99% is set forth in Section 6.4 of the Certificate of Designation for the Series B Preferred.
• · The issuer's common stock has a par value of $0.0001 per share.
• · The filing includes a certification that the securities were not acquired to change or influence control of the issuer.

23-06-2026

Moringa Sponsor, LP and related entities have filed an amended Schedule 13D (Amendment 3) for Silexion Therapeutics Corp, reporting aggregate beneficial ownership of 199,053 ordinary shares (10.6% of outstanding shares) as of June 14, 2026. However, the filing expressly disputes the validity of the issuances of 45,000 (September 2025), 92,500 (May 2026), and 60,819 (June 2026) ordinary shares, which the Issuer claims were issued in conversion of a total of $2.6 million outstanding under a $3.4 million promissory note. The reporting persons do not concede beneficial ownership of these disputed shares, indicating a significant disagreement over the legitimacy of those conversions.

• · Reverse share splits occurred three times: 1-for-9 on Nov 27, 2024; 1-for-15 on July 28, 2025; 1-for-10 on May 28, 2026.
• · On August 7, 2025, Moringa Sponsor, LP transferred 5,550 ordinary shares and 126,250 warrants to its limited partners with no consideration.
• · The reporting persons filed this amendment 'out of an abundance of caution' and expressly disclaim beneficial ownership of the disputed shares.
• · The Issuer had filed a Registration Statement on Form S-3 with the SEC on June 12, 2026.
• · The filing references prior amendments: Amendment 2 filed May 29, 2026; Amendment 1 filed September 23, 2025; Original 13D filed August 22, 2024.

23-06-2026

John Robert Foley filed a Schedule 13G with the SEC on June 23, 2026, reporting beneficial ownership of 950,000 Class A ordinary shares of WeShop Holdings Ltd, all of which are issuable upon exercise of options. The reported stake represents 7.62% of the company's outstanding shares, calculated based on 11,513,073 Class A ordinary shares outstanding as of June 19, 2026. However, the filing notes that Foley disclaims beneficial ownership of shares held by Max Capital Limited (773,822 shares) and that he and his spouse share voting and dispositive power over shares held by FFIH Limited (1,003,938 shares), which were separately reported in a prior Schedule 13G.

• · The filing is made under Rule 13d-1(d) of the Securities Exchange Act of 1934.
• · Foley disclaims beneficial ownership of the 773,822 shares held by Max Capital Limited, stating he does not have power to direct voting or dispositive decisions.
• · Foley and his spouse share voting and dispositive power over the 1,003,938 shares held by FFIH Limited, which were previously reported on a separate Schedule 13G filed June 12, 2026.
• · The 950,000 options are exercisable into Class A ordinary shares with no par value.
• · The filing includes a Power of Attorney (Exhibit 99.1) incorporated by reference from Foley's Form 3 filed June 11, 2026.

23-06-2026

Oaktree Capital entities filed Amendment No. 23 to their Schedule 13D for TORM plc, reporting a 19.86% beneficial ownership stake as of June 22, 2026. On that date, Oaktree sold 3,509,701 Class A shares at $29.08 per share in a block trade under Rule 144, reducing their holdings from a prior undisclosed level. The filing does not provide a prior period comparison for the ownership percentage, but the sale represents a notable reduction in Oaktree's position.

• · The filing is Amendment No. 23 to a Schedule 13D originally filed on February 5, 2018.
• · The sale was executed as a block trade under Rule 144.
• · No other transactions in Class A shares were effected since the prior Amendment No. 22 (filed March 6, 2026).
• · The beneficial ownership percentage is calculated based on 102,367,118 Class A shares outstanding as of June 2, 2026, per the issuer's Form 6-K.

23-06-2026

Murchinson Ltd. and affiliated entities filed Amendment No. 17 to their Schedule 13D, disclosing aggregate beneficial ownership of 20,285,450 American Depositary Shares (9.6% of outstanding shares) in Nano Dimension Ltd. as of June 22, 2026. The filing details recent share purchases by Nomis Bay Ltd., BPY Ltd., and Murchinson Ltd. between June 15-22, 2026, at prices ranging from $1.2634 to $1.3870 per share, and updates the group's joint filing agreement.

• · Nomis Bay Ltd. purchased 1,200,000 ADS at $1.3870 on June 22, 2026, the largest single transaction disclosed.
• · BPY Ltd. purchased 800,000 ADS at $1.3870 on June 22, 2026.
• · The group entered into a new Joint Filing Agreement dated June 23, 2026.
• · All shares were purchased with working capital, which may include margin loans from brokerage firms.
• · The filing is Amendment No. 17, indicating ongoing active monitoring and trading by the group.

23-06-2026

Atlas Investissement SAS, controlled by Iliad Holding SAS and ultimately by the Niel family, increased its beneficial ownership in Millicom International Cellular SA to 46.7% of outstanding shares (78,320,018 shares including an expected purchase of 1,250,000 additional Common Shares on June 29, 2026). The increase is facilitated by an amendment to the New Equity Derivative Transaction, which upsized the maximum equity notional amount and extended the final maturity date to June 29, 2026. However, the filing also reflects that Atlas Investissement elected cash settlement for three European-style call spread option transactions, indicating a shift in strategy for those derivative positions.

• · Atlas Investissement has irrevocably elected cash settlement for three European-style call spread option transactions on June 23, 2026.
• · The amendment to the Amended Equity Derivative Transaction Agreements increased the applicable maximum equity notional amount.
• · The final maturity date under the Amended Equity Derivative Transaction Agreements was amended to June 29, 2026.
• · The expected purchase of 1,250,000 Common Shares on June 29, 2026 is subject to the Bank's hedging position.
• · Atlas Investissement may fund the transaction through a future amendment to upsize an equity financing with unaffiliated third parties or via borrowings from affiliates.
• · The beneficial ownership percentage is calculated based on 167,707,493 Common Shares outstanding (excluding 1,292,507 treasury shares).

23-06-2026

Jane Street Group, LLC and its subsidiaries (Jane Street Capital, LLC and Jane Street Global Trading, LLC) filed a Schedule 13G with the SEC on June 23, 2026, disclosing beneficial ownership of 68,955 ordinary shares of Jiuzi Holdings, Inc., representing 5.2% of the outstanding shares as of June 16, 2026. The filing indicates passive investment intent under Rule 13d-1(c), with no intention to change or influence control of the issuer.

• · Filing was made pursuant to Rule 13d-1(c), indicating passive investment purposes.
• · Jane Street Capital, LLC holds 32,445 shares (2.4%) and Jane Street Global Trading, LLC holds 36,510 shares (2.8%).
• · All entities share a business address: 250 Vesey Street, 6th Floor, New York, NY 10281.
• · Each reporting person disclaims beneficial ownership except for their pecuniary interest.

23-06-2026

ECP ControlCo, LLC and affiliated entities filed a Schedule 13G with the SEC on June 23, 2026, disclosing beneficial ownership of 2,399,998 shares of Talen Energy Corp common stock, representing 5.01% of the 47,894,656 shares outstanding as of June 18, 2026. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · ECP ControlCo, LLC is the managing member of ECP V, LLC, which indirectly controls the other reporting entities.
• · The board of managers of ECP ControlCo, LLC collectively shares voting and dispositive power over the securities.
• · The filing includes a Joint Filing Agreement (Exhibit 99) among all reporting persons.

23-06-2026

Jane Street Group, LLC disclosed a 6.1% beneficial ownership stake in Sleep Number Corp (SNBR) as of June 16, 2026, holding 1,401,197 shares of common stock. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer. The filing includes holdings by subsidiaries Jane Street Capital, LLC (2.5%) and Jane Street Global Trading, LLC (3.6%).

• · The filing is a Schedule 13G (passive investment), not a 13D (activist), indicating the stake is not intended to influence control.
• · Jane Street Group, LLC is a Delaware limited liability company with business address at 250 Vesey Street, 6th Floor, New York, NY 10281.
• · The filing date is June 23, 2026, and the event date is June 16, 2026.
• · Sleep Number Corp is incorporated in Minnesota with fiscal year ending in January (0103) and SIC code 2510 (Household Furniture).

23-06-2026

Tai Wey Ann filed a Schedule 13G with the SEC on June 23, 2026, disclosing beneficial ownership of 100,000 shares of Aditxt, Inc. common stock, representing 12.3% of the outstanding shares. The filing indicates that the shares were acquired and are held for investment purposes without intent to influence control of the issuer.

• · The filing was made under Rule 13d-1(c), indicating passive investment intent.
• · Tai Wey Ann's address is in Singapore (60 Paya Lebar Road, #06-28 Paya Lebar Square, Singapore 409051).
• · The filing certifies that the securities were not acquired with the purpose of changing or influencing control of Aditxt, Inc.

23-06-2026

Fairholme Capital Management, Bruce R. Berkowitz, and Fairholme Funds filed a Schedule 13D/A on June 23, 2026, disclosing their aggregate beneficial ownership in St. Joe Co. As of the filing, Berkowitz beneficially owns 18,182,367 shares (31.7%), Fairholme Capital Management owns 16,272,400 shares (28.3%), and Fairholme Funds owns 15,073,624 shares (26.3%). Since the last amendment, the Reporting Persons sold a total of 622,200 shares in open-market transactions between May 8 and June 18, 2026, at prices ranging from $65.03 to $66.09 per share, indicating a reduction in their position.

• · The filing is an amendment to the initial Schedule 13D filed on October 14, 2010, with no material changes from the October 23, 2024 amendment or the April 26, 2017 filing.
• · Fairholme Capital Management has shared power to vote and dispose of 16,272,400 shares; Fairholme Funds has shared power over 15,073,624 shares; Berkowitz has sole power to vote and dispose of 1,909,967 shares and shared power over 15,073,624 shares.
• · All sell transactions were executed in open market at prices between $65.03 and $66.09 per share.
• · The largest single sale was 140,400 shares on June 18, 2026 at $65.71.

23-06-2026

Laurence W. Lytton and affiliated entities (Lytton-Kambara Foundation, AWL Family LLC) filed a Schedule 13G on June 23, 2026, disclosing combined beneficial ownership of 1,026,424 shares (9.9%) of DATA I/O CORP common stock. The filing reports 9,394,422 shares outstanding as of April 30, 2026, and includes shares held via common stock, warrants, and convertible notes, all subject to a 9.99% beneficial ownership limitation. No period-over-period changes are provided in this initial filing.

• · The filing is under Rule 13d-1(c), indicating passive investment intent.
• · Lytton beneficially owns 145,540 shares directly (sole voting and dispositive power) and 880,884 shares indirectly (shared voting and dispositive power).
• · Lytton-Kambara Foundation beneficially owns 590,374 shares (all indirect).
• · AWL Family LLC beneficially owns 300,208 shares (all indirect).
• · All warrants and convertible notes are subject to a 9.99% beneficial ownership limitation.
• · The percentage calculations are based on 9,394,422 shares outstanding plus 1,016,163 shares issued in the private placement.
• · A joint filing agreement (Exhibit 99.1) was executed among the reporting persons.

23-06-2026

Fairmount Funds Management LLC and related parties disclosed that on June 18, 2026, Apogee Therapeutics entered into a merger agreement with an affiliate of AbbVie Inc., whereby each share of common stock will be converted into the right to receive $135.11 per share in cash. Fairmount, which beneficially owns approximately 9.84% of Apogee's outstanding common stock (6,713,519 shares), has entered into a voting agreement committing to support the merger. Concurrently, Fund II delivered a written consent approving the merger on behalf of non-voting stockholders.

• · Fairmount Funds Management LLC holds 6,713,519 shares of Apogee common stock (9.84% of total) as of June 18, 2026.
• · Fund II directly holds 298,647 shares of common stock and 6,414,872 shares of non-voting common stock (with 9.99% beneficial ownership limitation).
• · Peter Harwin resigned from Apogee's board on May 11, 2026; the resignation was not due to any disagreement with the company.
• · On June 17, 2026, Tomas Kiselak's stock options to purchase 14,461 shares of common stock (exercise price $41.66 per share) vested in full.
• · The merger requires approval of both a majority of common stock and, while at least 6,061,821 shares of non-voting common stock remain outstanding, a majority of non-voting common stock.
• · The voting agreement includes an irrevocable proxy if Fund II fails to deliver a proxy card two business days before the relevant meeting.
• · The merger agreement was filed on Form 8-K by Apogee on June 22, 2026.

23-06-2026

Tenor Capital Management Company, L.P., Tenor Opportunity Master Fund, Ltd., and Robin Shah filed a Schedule 13G indicating beneficial ownership of 1,500,000 units (each unit consists of one Class A ordinary share and one-third of one redeemable warrant) of Yorkville International Capital Corp., representing approximately 6.5% of the 23,000,000 outstanding units as of June 17, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

• · Each unit consists of one Class A ordinary share ($0.0001 par value) and one-third of one redeemable warrant.
• · Tenor Capital Management Company, L.P. serves as investment manager to Tenor Opportunity Master Fund, Ltd., and Robin Shah is managing member of Tenor Management GP, LLC (general partner of Tenor Capital).
• · The filing is made pursuant to Rule 13d-1(c), indicating the securities were not acquired with the purpose of changing control.

23-06-2026

Stonepine Capital Management, LLC and related entities filed a Schedule 13G disclosing beneficial ownership of 1,952,550 shares of Pasithea Therapeutics Corp. common stock, representing a 5.8% stake as of June 17, 2026. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer. The reporting persons include Stonepine Capital Management, LLC, Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico, each disclaiming membership in a group and beneficial ownership beyond their pecuniary interest.

• · The filing is made under Rule 13d-1(c), indicating the securities were not acquired to change or influence control.
• · Each reporting person disclaims beneficial ownership except for their pecuniary interest, and disclaims membership in a group.
• · The Partnership (Stonepine Capital, L.P.) holds the shares for the benefit of its investors and has the right to receive dividends or proceeds from sale.
• · A joint filing agreement dated October 10, 2024, is included as Exhibit 99.

23-06-2026

Joseph Stilwell and affiliated entities (the Group) filed a Schedule 13D/A disclosing beneficial ownership of 406,874 shares (9.7%) of Central Plains Bancshares, Inc. (CPBI) common stock. The Group has nominated Francis E. Younes for election to the board at the 2026 annual meeting and submitted a non-binding proposal to repurchase at least 10% of outstanding shares annually when the stock trades below book value. Since the prior filing, Stilwell Activist Investments spent $732,281.06 to acquire 39,973 additional shares, while other Group members made no purchases or sales.

• · The Group has taken activist positions in 79 other publicly-traded companies since 2000.
• · Stilwell Activist Fund and Stilwell Partners have not purchased or sold any shares since the last filing.
• · The Group's shares are held through margin accounts with Morgan Stanley, Interactive Brokers, or J.P. Morgan.
• · The Nominee Agreements with Younes and Novotny include reimbursement of out-of-pocket expenses and indemnification.
• · The filing is the third amendment to the original Schedule 13D filed November 5, 2024.

23-06-2026

ICS Opportunities, Ltd. and related entities (Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander) filed a Schedule 13G on June 23, 2026, disclosing that as of June 16, 2026, they collectively held 58,621 ordinary shares of Arqit Quantum Inc., representing 0.3% of the class. However, the filing states that after acquiring beneficial ownership of more than 5% of the outstanding shares on June 16, 2026, the reporting persons ceased to be beneficial owners of more than 5% by the date of the filing, indicating a significant reduction in their stake.

• · ICS Opportunities, Ltd. held sole voting power over 7,800 shares (0.0% of class) and sole dispositive power over 7,800 shares.
• · The reporting persons ceased to be beneficial owners of more than 5% of the outstanding ordinary shares by the date of the filing.
• · The filing was made pursuant to Rule 13d-1(c), indicating the filers are passive investors not seeking to influence control.
• · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Israel A. Englander.

23-06-2026

Jabbok Schlacks and William J. Schlacks IV, co-founders and executives of EquipmentShare.com Inc, filed a Schedule 13D disclosing joint beneficial ownership of 34,828,852 shares of Class A common stock (on an as-converted basis), representing approximately 14.9% of total outstanding common stock. However, due to a voting agreement and the 20-vote-per-share structure of Class B stock, the two individuals collectively control 81% of the total voting power, giving them effective control over the company.

• · Each share of Class B common stock is convertible into one share of Class A common stock at the holder's option.
• · The co-founders have a voting agreement to vote their shares together as a group.
• · The filing indicates the shares were acquired using personal funds and/or as compensation for executive and board service.
• · The reporting persons may consider extraordinary corporate transactions including a merger, reorganization, or take-private that could result in de-listing or de-registration of Class A common stock.
• · No criminal convictions or securities law violations for either reporting person in the last five years.

23-06-2026

Mark Taylor and affiliated entities (Prospect Capital Securities Ltd and Prospect Finance Ltd) filed an exit filing on Schedule 13D/A, indicating they ceased to be beneficial owners of more than 5% of CDT Equity Inc. common stock. On June 18, 2026, the group sold all remaining shares—Prospect Capital sold 1,469,711 shares ($0.7052 to $1.44 per share) and Prospect Finance sold 598,289 shares ($0.751 to $1.67 per share)—reducing their combined ownership to 0.0% of the 4,722,458 shares outstanding as of June 22, 2026. This represents a complete exit from a previously material position.

• · The group's exit filing confirms they no longer hold any shares of CDT Equity common stock as of June 22, 2026.
• · Prospect Capital's sale included two blocks: 5,000 shares at $0.7052 and 1,464,711 shares at $1.44 per share.
• · Prospect Finance's sale included a block of 5,000 shares at $0.751 and 593,289 shares at prices ranging from $1.23 to $1.67 per share.
• · The issuer effected a 1-for-25 reverse stock split effective March 26, 2026; all share numbers reflect this split.
• · No other transactions in the common stock by the Reporting Persons occurred during the 60 days prior to the filing.

23-06-2026

KKR entities, including KKR Alternative Assets L.P., filed a Schedule 13D disclosing beneficial ownership of 7.8% of FS KKR Capital Corp. common stock (22,582,961 shares) as of June 15, 2026. The filing details a tender offer that closed on June 15, 2026, where KKR purchased 13,636,363 shares for $150 million at $11.00 per share, and a separate agreement to purchase $150 million in newly issued convertible perpetual preferred stock (5.00% dividend, increasing after 5.5 years) expected to close on June 29, 2026. The filing also notes that FS/KKR Advisor, LLC, the Issuer's external manager, is jointly operated by a KKR affiliate and a Franklin Square affiliate, and certain Issuer officers/directors are KKR employees, indicating potential influence over corporate activities.

23-06-2026

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G disclosing beneficial ownership of 7,323,520 shares of Maravai LifeSciences Holdings, Inc. Class A Common Stock, representing 4.96% of the outstanding shares as of June 16, 2026. The filing indicates that after acquiring more than 5% ownership on June 16, 2026, the reporting persons subsequently fell below the 5% threshold by the filing date, reflecting a reduction in their stake.

• · The reporting persons acquired beneficial ownership of more than 5% on June 16, 2026, but subsequently fell below 5% by the filing date.
• · The filing is made pursuant to Rule 13d-1(c), indicating the securities were not acquired with the purpose of changing or influencing control of the issuer.
• · A Joint Filing Agreement was executed on June 22, 2026, among Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.

23-06-2026

Madison Avenue International LP, along with related entities and Eli Samaha, disclosed beneficial ownership of 3,606,203 ordinary shares (no par value) of Lakefront Biotherapeutics NV (formerly Galapagos NV), representing approximately 5.5% of the outstanding shares as of June 23, 2026. The filing is a Schedule 13G, indicating a passive investment intent. The percentage ownership is based on the issuer's outstanding share count of 65,897,071 as of December 31, 2025.

• · The filing was made pursuant to Rule 13d-1(c), confirming a passive investment stance.
• · The issuer's name changed from Galapagos NV to Lakefront Biotherapeutics NV on December 20, 2007.
• · All Reporting Persons share a business address at 150 East 58th St, 14th Fl, New York, NY 10155.
• · Eli Samaha is a U.S. citizen and may be deemed to have the same beneficial ownership through his control of the reporting entities.

23-06-2026

CW Opportunity LLC filed an amended Schedule 13G with the SEC on June 23, 2026, reporting a 4.4% beneficial ownership stake in CoreWeave, Inc. as of April 30, 2026, representing 19,886,405 shares of Class A common stock. This amendment is the final filing and constitutes an exit filing for the reporting person, indicating that CW Opportunity LLC has reduced its holdings below the 5% threshold or ceased to be a major shareholder.

• · The filing is an exit filing, meaning CW Opportunity LLC no longer holds 5% or more of CoreWeave's common stock.
• · The original Schedule 13G was filed on April 1, 2025.
• · The shares are held directly by CW Opportunity LLC, a Delaware limited liability company.
• · The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

23-06-2026

Astaris Capital Management LLP and related entities increased their beneficial ownership in KNOT Offshore Partners LP to 8.0% (2,695,018 Common Units) as of June 18, 2026, up from a prior lower stake, triggering this Schedule 13D/A filing. The filing also references a non-binding offer letter from KNOT dated October 31, 2025, to acquire all outstanding Common Units not already owned by KNOT, with which the Reporting Persons have engaged and may continue to discuss. The increased stake reflects open-market purchases at prices between $10.22 and $11.42 per unit during the past 60 days, with no borrowed funds used for the acquisitions.

• · Filing type is Schedule 13D/A (Amendment No. 3), filed June 23, 2026.
• · The Reporting Persons include Astaris Capital Management LLP, Astaris Capital Management (UK) Limited, Astaris Capital Management (Cayman) Limited, and Martin Beck.
• · All Reporting Persons share voting and dispositive power over the 2,695,018 Common Units (shared power). Each individually has sole power over 0 units.
• · No Reporting Person has been convicted in a criminal proceeding or subject to securities-related civil judgments in the last five years.
• · The acquired securities were purchased using working capital of private funds and managed account clients; no borrowed funds were used.
• · The Offer Letter from KNOT (October 31, 2025) proposes cash acquisition of all outstanding Common Units not already owned by KNOT.
• · The Reporting Persons disclaim membership in a group and disclaim beneficial ownership beyond pecuniary interest.
• · Exhibit B lists 18 open-market purchases totaling 2,695,018 units at prices from $10.22 to $11.42 between April 30, 2026 and June 18, 2026.
• · Total outstanding Common Units as of December 31, 2025: 33,660,342 (per Issuer's Form 20-F filed April 17, 2026).

23-06-2026

Activist shareholder Howard Todd Horberg, beneficially owning 5.61% (783,000 shares) of Equus Total Return, Inc. (EQS), filed a Schedule 13D on June 23, 2026, and issued an open letter sharply criticizing the board's stewardship. He cites a 65% decline in total net asset value (from $48.2M to $16.6M) over two years, five consecutive years of net investment losses, a stock price below NYSE listing threshold, and no dividends since 2009 — while executive compensation totaled $1.87M in 2025, equivalent to ~22% of non-affiliate market cap. Horberg calls for an independent strategic review, a suspension of automatic salary escalators, and a potential merger or acquisition by an operating company.

• · Shares acquired: 16,500 at $1.23 on June 15, 2026 (Horberg Enterprises LP); 5,500 at $1.22 on June 18, 2026 (Horberg Enterprises LP); 10,000 at $1.24 on June 18, 2026 (Todd Horberg Rollover IRA).
• · The CEO's base salary escalates annually by the greater of 5% or Canadian CPI; secretary's escalates by U.S. CPI — both contractually guaranteed regardless of performance.
• · The independent auditor included a going-concern explanatory paragraph in its audit report for FY2025.
• · Morgan E&P recorded a net loss of $7.0 million in 2025.
• · Directors and executive officers as a group control approximately 30.5% of outstanding shares, overwhelmingly concentrated in the CEO.
• · Second major shareholder holds 22.71% of shares.

23-06-2026

Victor Vega filed a Schedule 13D with the SEC on June 23, 2026, disclosing beneficial ownership of 19,552,066 shares of Arax Holdings Corp. common stock, representing 9.7% of the approximately 201,585,818 total outstanding shares. The shares were acquired through conversion of multiple 10% Convertible Promissory Notes and as payment for services as a Board Advisory Committee member.

• · The shares were acquired through conversion of multiple 10% Convertible Promissory Notes and as payment for a Statement of Work (SOW) for service as a Board Advisory Committee member.
• · Victor Vega is an Owner/Consultant of Vega Consulting Group HTX, LLC, based in Houston, TX.
• · The filing was made by Victor Vega as an individual shareholder, not as part of a group.

23-06-2026

Thomas John Corley filed a Schedule 13G/A with the SEC on June 23, 2026, disclosing beneficial ownership of 9,001,000 shares of GD Culture Group Ltd common stock, representing 14.8% of the 60,759,711 shares outstanding as of April 10, 2026. The filing indicates Corley has sole voting and dispositive power over all shares, and certifies the securities were not acquired with the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · Corley's address is 132 Washington Place, State College, PA 16801.
• · The filing was made under Rule 13d-1(c), indicating the filer is a passive investor.
• · The issuer's business address is 111 Town Square Place, Suite #1203, Jersey City, NJ 07310.
• · GD Culture Group Ltd was formerly known as Code Chain New Continent Ltd (name change May 18, 2020), TMSR HOLDING Co Ltd (name change February 7, 2018), and JM Global Holding Co (name change May 5, 2015).

23-06-2026

HPW Investments Holding Ltd. filed a Schedule 13G with the SEC on June 23, 2026, disclosing beneficial ownership of 3,435,501 common shares of Lakewood-Amedex Biotherapeutics Inc. (LABT), representing 24.04% of the 14,290,892 shares outstanding as of March 31, 2026. The filing indicates HPW Investments is a significant shareholder with a stake exceeding 20%, but no change in ownership or intent to influence control is implied by the 13G filing.

• · The filing is a Schedule 13G (passive investment) rather than a 13D (activist), indicating no intent to influence control.
• · HPW Investments is based in Jersey, Channel Islands (non-U.S. entity).
• · The filing date is June 23, 2026, and the ownership date is April 23, 2026.
• · HPW Investments holds sole voting and dispositive power over all 3,435,501 shares.

23-06-2026

Santa Venerina Inv. & Arbitrage Ltd. filed a Schedule 13G/A with the SEC on June 23, 2026, disclosing a 12.7% beneficial ownership stake in Waldencast plc, representing 15,000,000 Class A ordinary shares. The filing notes that this ownership reflects the receipt of 5,000,000 shares in an in-kind distribution by Beauty Ventures LLC, and the shares are held for passive investment purposes, not to influence control.

• · The filing is an amendment to Schedule 13G, indicating a change in beneficial ownership.
• · The shares were acquired via an in-kind distribution from Beauty Ventures LLC, not through open market purchases.
• · The filer certifies the shares are not held for the purpose of changing or influencing control of the issuer.

23-06-2026

On June 22, 2026, TIGH II, LLC and Anita G. Zucker sold all 586,468 shares of American Shared Hospital Services (AMS) common stock in a private transaction to RCS/TIG Holdings, LLC, an affiliate of executive chairman Raymond C. Stachowiak, at $2.28 per share for total proceeds of $1,337,147. As a result, both TIGH II and Mrs. Zucker ceased to be beneficial owners of 5% or more of AMS outstanding shares. No negative or flat metrics are present in this filing.

• · The filing is Amendment No. 3 to Schedule 13D, supplementing the initial filing from November 20, 2024.
• · The shares were sold in a private transaction, not on the open market.
• · RCS/TIG Holdings, LLC is affiliated with Raymond C. Stachowiak, the Company's executive chairman.

23-06-2026

Eric Benaim, CEO of Modern Spaces LLC, filed a Schedule 13D with the SEC on June 23, 2026, reporting beneficial ownership of 81,175 shares of La Rosa Holdings Corp. (LRHC) common stock, representing 5.02% of the outstanding shares. All shares were acquired through open market purchases between June 6 and June 18, 2026, for a total of $83,610.25, with purchases ranging from $0.96 to $1.13 per share.

• · Eric Benaim acquired all 81,175 shares through open market purchases executed via a personal brokerage account.
• · No broker-dealer acted as principal in the transactions.
• · Benaim has sole voting and dispositive power over all reported shares, with no shared power.
• · No other person has rights to dividends or proceeds from the shares.
• · The shares outstanding used for percentage calculation (1,616,081) were reported in the Issuer's June 4, 2026 Form 10-K.
• · Individual purchase transactions ranged from 1 to 14,050 shares at prices from $0.96 to $1.13 per share.

23-06-2026

Fiduciary Management Inc. filed a Schedule 13G with the SEC on June 23, 2026, reporting beneficial ownership of 1,875,277 shares of Insight Enterprises Inc. common stock, representing 6.23% of the outstanding shares. The filing indicates passive investment intent under Rule 13d-1(b).

• · Fiduciary Management Inc. has sole voting power over 1,672,591 shares and sole dispositive power over 1,875,277 shares.
• · The filing is made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not for changing or influencing control.

23-06-2026

Fiduciary Management Inc. filed a Schedule 13G with the SEC on June 23, 2026, disclosing beneficial ownership of 903,400 shares of Huron Consulting Group Inc. common stock, representing a 5.45% stake. The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

• · Fiduciary Management Inc. is based in Milwaukee, Wisconsin (790 N. Water Street, Suite 2100).
• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · Fiduciary Management Inc. has sole voting power over 805,674 shares and sole dispositive power over 903,400 shares.
• · The filer certifies that the securities were acquired and are held in the ordinary course of business and not with the purpose of changing or influencing control.
• · The filing date is June 23, 2026, and the event date is as of change for the same date.